Johnson & Johnson
JNJ
NYSE
$178.08
$1.230.70%
Volume531
05/16/2022 4:00PM Eastern
Quotes delayed
| Weiss Ratings | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | -- | ||
| Risk Index | Good | -- | ||
| Risk Grade | B | -- | ||
| Reward Grade | B+ | -- | ||
| Rating Factors | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Dividend Index | Fair | -- | ||
| Growth Index | Good | -- | ||
| Efficiency Index | Excellent | -- | ||
| Solvency Index | Excellent | -- | ||
| Total Return Index | Good | -- | ||
| Volatility Index | Good | -- | ||
| Beta / Standard Deviation | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Beta | 0.54 | -- | ||
| Price History | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.05% | -- | ||
| 30-Day Total Return | -0.75% | -- | ||
| 60-Day Total Return | 6.46% | -- | ||
| 90-Day Total Return | 2.71% | -- | ||
| Year to Date Total Return | 3.12% | -- | ||
| 1-Year Total Return | 3.99% | -- | ||
| 2-Year Total Return | 20.83% | -- | ||
| 3-Year Total Return | 31.67% | -- | ||
| 5-Year Total Return | 44.79% | -- | ||
| 52-Week High % Change | -5.27% | -- | ||
| 52-Week Low % Change | 13.57% | -- | ||
| Price | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| 52-Week High Price | $186.69 | -- | ||
| 52-Week Low Price | $155.72 | -- | ||
| 52-Week Low Price (Date) | Feb 24, 2022 | -- | ||
| 52-Week High Price (Date) | Apr 25, 2022 | -- | ||
| Valuation | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Market Cap | $465.36B | -- | ||
| Enterprise Value | 466.24B | -- | ||
| Price/Earnings (TTM) | 23.83 | -- | ||
| Earnings Per Share (TTM) | 7.42 | -- | ||
| Earnings Per Share Growth | 31.09% | -- | ||
| Price/Earnings To Growth | 0.77 | -- | ||
| Price/Sales (TTM) | 4.97 | -- | ||
| Price/Book (Q) | 6.22 | -- | ||
| Enterprise Value/Revenue (TTM) | 4.91 | -- | ||
| Price | $176.85 | -- | ||
| Enterprise Value/EBITDA (TTM) | 14.39 | -- | ||
| Enterprise Value/EBIT | 18.54 | -- | ||
| Market Cap Category | Mega Cap | -- | ||
| Dividends and Shares | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Shares Outstanding | 2.667B | -- | ||
| Dividend Yield | 2.40% | -- | ||
| Div. Per Share (Most Recent) | $1.06 | -- | ||
| Dividend Per Share (TTM) | $4.24 | -- | ||
| Payout Ratio (TTM) | 56.28% | -- | ||
| Dividend Per Share (Most Recent) | $1.06 | -- | ||
| Company Info | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Phone Number | 732 524 0400 | -- | ||
| Address | One Johnson & Johnson Plaza New Brunswick, NJ 08933 | -- | ||
| Website | www.jnj.com | -- | ||
| Country | United States | -- | ||
| Year Founded | 1886 | -- | ||
| Profitability | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 26.50% | -- | ||
| Profit Margin | 20.90% | -- | ||
| Management Effectiveness | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Return on Assets | 8.96% | -- | ||
| Return on Equity | 28.22% | -- | ||
| Income Statement | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Revenue (TTM) | $94.88B | -- | ||
| Total Revenue (TTM) | $94.88B | -- | ||
| Revenue Per Share | $35.58 | -- | ||
| Gross Profit (TTM) | $64.58B | -- | ||
| EBITDA (TTM) | $32.41B | -- | ||
| EBIT (TTM) | $25.15B | -- | ||
| Net Income (TTM) | $19.83B | -- | ||
| Net Income Avl. to Common (TTM) | $19.83B | -- | ||
| Total Revenue Growth (Q YOY) | 4.95% | -- | ||
| Earnings Growth (Q YOY) | -16.91% | -- | ||
| EPS Diluted (TTM) | $7.42 | -- | ||
| EPS Diluted Growth (Q YOY) | -16.81% | -- | ||
| Balance Sheet | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | $30.39B | -- | ||
| Cash Per Share (Q) | $11.40 | -- | ||
| Total Current Assets (Q) | $60.42B | -- | ||
| Total Preferred Equity (Q) | -- | -- | ||
| Total Equity (Q) | $74.71B | -- | ||
| Current Ratio (Q) | 1.393 | -- | ||
| Book Value Per Share (Q) | $28.41 | -- | ||
| Total Assets (Q) | $178.36B | -- | ||
| Total Current Liabilities (Q) | $43.39B | -- | ||
| Total Debt (Q) | $33.15B | -- | ||
| Total Liabilities (Q) | $103.65B | -- | ||
| Total Common Equity (Q) | $74.71B | -- | ||
| Cash Flow | JNJ - NYSE | - | Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -$12.13B | -- | ||
| Cash from Financing (TTM) | -$13.31B | -- | ||
| Net Change in Cash (TTM) | -$2.21B | -- | ||
| Levered Free Cash Flow (TTM) | $19.20B | -- | ||
| Cash from Operations (TTM) | $23.32B | -- | ||
